103 related articles for article (PubMed ID: 21288692)
1. Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients.
Mühleisen TW; Basmanav FB; Forstner AJ; Mattheisen M; Priebe L; Herms S; Breuer R; Moebus S; Nenadic I; Sauer H; Mössner R; Maier W; Rujescu D; Ludwig M; Rietschel M; Nöthen MM; Cichon S
Schizophr Res; 2011 Apr; 127(1-3):35-40. PubMed ID: 21288692
[TBL] [Abstract][Full Text] [Related]
2. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.
Suárez-Rama JJ; Arrojo M; Sobrino B; Amigo J; Brenlla J; Agra S; Paz E; Brión M; Carracedo Á; Páramo M; Costas J
J Psychiatr Res; 2015; 66-67():38-44. PubMed ID: 25943950
[TBL] [Abstract][Full Text] [Related]
3. Incomplete penetrance of NRXN1 deletions in families with schizophrenia.
Todarello G; Feng N; Kolachana BS; Li C; Vakkalanka R; Bertolino A; Weinberger DR; Straub RE
Schizophr Res; 2014 May; 155(1-3):1-7. PubMed ID: 24680031
[TBL] [Abstract][Full Text] [Related]
4. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
[TBL] [Abstract][Full Text] [Related]
5. Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.
Xing J; Wang C; Kimura H; Takasaki Y; Kunimoto S; Yoshimi A; Nakamura Y; Koide T; Banno M; Kushima I; Uno Y; Okada T; Aleksic B; Ikeda M; Iwata N; Ozaki N
PLoS One; 2014; 9(11):e112531. PubMed ID: 25393624
[TBL] [Abstract][Full Text] [Related]
6. Rare NRXN1 promoter variants in patients with schizophrenia.
Shah AK; Tioleco NM; Nolan K; Locker J; Groh K; Villa C; Stopkova P; Pedrosa E; Lachman HM
Neurosci Lett; 2010 May; 475(2):80-4. PubMed ID: 20347009
[TBL] [Abstract][Full Text] [Related]
7. Rare UNC13B variations and risk of schizophrenia: Whole-exome sequencing in a multiplex family and follow-up resequencing and a case-control study.
Egawa J; Hoya S; Watanabe Y; Nunokawa A; Shibuya M; Ikeda M; Inoue E; Okuda S; Kondo K; Saito T; Kaneko N; Muratake T; Igeta H; Iwata N; Someya T
Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):797-805. PubMed ID: 26990377
[TBL] [Abstract][Full Text] [Related]
8. Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.
Souza RP; Meltzer HY; Lieberman JA; Le Foll B; Kennedy JL
Hum Psychopharmacol; 2010 Nov; 25(7-8):582-5. PubMed ID: 20860064
[TBL] [Abstract][Full Text] [Related]
9. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy.
Møller RS; Weber YG; Klitten LL; Trucks H; Muhle H; Kunz WS; Mefford HC; Franke A; Kautza M; Wolf P; Dennig D; Schreiber S; Rückert IM; Wichmann HE; Ernst JP; Schurmann C; Grabe HJ; Tommerup N; Stephani U; Lerche H; Hjalgrim H; Helbig I; Sander T;
Epilepsia; 2013 Feb; 54(2):256-64. PubMed ID: 23294455
[TBL] [Abstract][Full Text] [Related]
10. Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family.
Duong LT; Hoeffding LK; Petersen KB; Knudsen CD; Thygesen JH; Klitten LL; Tommerup N; Ingason A; Werge T
Eur J Med Genet; 2015 Dec; 58(12):650-3. PubMed ID: 26563496
[TBL] [Abstract][Full Text] [Related]
11. Investigation of NRXN1 deletions: clinical and molecular characterization.
Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the neurexin 1 gene is associated with schizophrenia.
Rujescu D; Ingason A; Cichon S; Pietiläinen OP; Barnes MR; Toulopoulou T; Picchioni M; Vassos E; Ettinger U; Bramon E; Murray R; Ruggeri M; Tosato S; Bonetto C; Steinberg S; Sigurdsson E; Sigmundsson T; Petursson H; Gylfason A; Olason PI; Hardarsson G; Jonsdottir GA; Gustafsson O; Fossdal R; Giegling I; Möller HJ; Hartmann AM; Hoffmann P; Crombie C; Fraser G; Walker N; Lonnqvist J; Suvisaari J; Tuulio-Henriksson A; Djurovic S; Melle I; Andreassen OA; Hansen T; Werge T; Kiemeney LA; Franke B; Veltman J; Buizer-Voskamp JE; ; Sabatti C; Ophoff RA; Rietschel M; Nöthen MM; Stefansson K; Peltonen L; St Clair D; Stefansson H; Collier DA
Hum Mol Genet; 2009 Mar; 18(5):988-96. PubMed ID: 18945720
[TBL] [Abstract][Full Text] [Related]
13. Exonic resequencing of the DLGAP3 gene as a candidate gene for schizophrenia.
Li JM; Lu CL; Cheng MC; Luu SU; Hsu SH; Chen CH
Psychiatry Res; 2013 Jun; 208(1):84-7. PubMed ID: 23414653
[TBL] [Abstract][Full Text] [Related]
14. Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia.
Wang C; Koide T; Kimura H; Kunimoto S; Yoshimi A; Nakamura Y; Kushima I; Banno M; Kawano N; Takasaki Y; Xing J; Noda Y; Mouri A; Aleksic B; Ikeda M; Okada T; Iidaka T; Inada T; Iwata N; Ozaki N
Schizophr Res; 2014 Aug; 157(1-3):149-56. PubMed ID: 24878430
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the NRXN1 gene in a Chinese autism cohort.
Liu Y; Hu Z; Xun G; Peng Y; Lu L; Xu X; Xiong Z; Xia L; Liu D; Li W; Zhao J; Xia K
J Psychiatr Res; 2012 May; 46(5):630-4. PubMed ID: 22405623
[TBL] [Abstract][Full Text] [Related]
16. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders.
Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N
Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.
Lowther C; Speevak M; Armour CM; Goh ES; Graham GE; Li C; Zeesman S; Nowaczyk MJ; Schultz LA; Morra A; Nicolson R; Bikangaga P; Samdup D; Zaazou M; Boyd K; Jung JH; Siu V; Rajguru M; Goobie S; Tarnopolsky MA; Prasad C; Dick PT; Hussain AS; Walinga M; Reijenga RG; Gazzellone M; Lionel AC; Marshall CR; Scherer SW; Stavropoulos DJ; McCready E; Bassett AS
Genet Med; 2017 Jan; 19(1):53-61. PubMed ID: 27195815
[TBL] [Abstract][Full Text] [Related]
19. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility.
Kushima I; Nakamura Y; Aleksic B; Ikeda M; Ito Y; Shiino T; Okochi T; Fukuo Y; Ujike H; Suzuki M; Inada T; Hashimoto R; Takeda M; Kaibuchi K; Iwata N; Ozaki N
Schizophr Bull; 2012 May; 38(3):552-60. PubMed ID: 21041834
[TBL] [Abstract][Full Text] [Related]
20. Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia.
Iatropoulos P; Gardella R; Valsecchi P; Magri C; Ratti C; Podavini D; Rossi G; Gennarelli M; Sacchetti E; Barlati S
Psychiatr Genet; 2009 Oct; 19(5):237-43. PubMed ID: 19641478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
